Skip to content
healthcare.dev

Columvi

NDC 50242-125, Glofitamab, solution, concentrate, from Genentech, Inc..

Product NDC
50242-125
Status
Listed
Labeler
Genentech, Inc.
Dosage form
SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761309
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLOFITAMAB2.5 mg/2.5mL

Pharmacologic classes

Bispecific CD20-directed CD3 T Cell Engager [EPC]; CD20-directed Antibody Interactions [MoA]; CD3 Receptor Agonists [MoA]; CD3-directed Antibody Interactions [MoA]; Cytochrome P450 Inhibitors [MoA]; Increased Cytokine Activity [PE]

Package NDCNDC-11Package
50242-125-01502420125011 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3516e753-f064-4d30-9bd5-e3f2e143f75d
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-125

Use it

Look up 50242-125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.